关于3,4,5-三甲氧基肉桂酸 90-50-6价格的CAS号、分子式、分子量、结构式、COA(产品质量报告)、级别、规格、含量、熔点、性状、用途、保存、纯度、折光率、密度、沸点、库存量等,请看以下产品详细介绍!
产品名称 | 3,4,5-三甲氧基肉桂酸 90-50-6价格
|
英文名称
| 3,4,5-Trimethoxycinnamic acid
|
CAS号
| 90-50-6
|
中文名称:
3,4,5-三甲氧基肉桂酸 90-50-6价格其他中文名称: 3,4,5-三甲氧基苯乙烯酸;3,4,5-三甲氧基苯丙烯酸;3-(3,4,5-三甲氧基)苯基-2-丙烯
英文名称: 3,4,5-Trimethoxycinnamic acid
其他英文名称: 3-(3,4,5-Trimethoxy) phenyl-2-propenoic acid
产品规格: AR,99%
包 装: 5克/25克/100克/500克
CAS号:90-50-6
C12H14O5=238.24
级别:AR
含量:≥99%
熔点:126~128℃
性状:至微黄色粉末或针状结晶。 为顺、反异构体混合物,但主要是反式。溶于热水和*
用途:生化研究。有机合成
保存:RT
3,4,5-三甲氧基肉桂酸 90-50-6价格主要优级纯、分级纯和化学纯3种:
(1)优级纯(GR:Guaranteed reagent),又称一级品或保证试剂,99.8%,这种试剂纯度Z高,杂质含量Z低,适合于重要精密的分析工作和科学研究工作,使用绿色瓶签。
(2)分析纯(AR),又称二级试剂,纯度很高,99.7%,略次于优级纯,适合于重要分析及一般研究工作,使用红色瓶签。
(3)化学纯(CP),又称三级试剂,≥ 99.5%,纯度与分析纯相差较大,适用于工矿、学校一般分析工作。使用蓝色(深蓝色)标签。
(4)实验试剂(LR:Laboratory reagent),又称四级试剂。
3,4,5-三甲氧基肉桂酸 90-50-6价格公司主营产品:
生化试剂:抗生素、维生素、培养基、染色剂、酶/辅酶、碳水化合物、分离试剂、缓冲试剂、核酸及衍生物、氨基酸/蛋白质等其它生化试剂,我们提供各品Pai。
分子生物学:核酸电泳、DNA Marker、克隆表达、PCR/Q-PCR、RT-PCR、基因组提取、质粒提取、RNA提取、DNA纯化回收、核酸纯化相关试剂。
细胞培养:血清、培养基、平衡盐溶液、辅助添加试剂、细胞检测试验。
蛋白质研究:蛋白电泳、蛋白提取、蛋白纯化、蛋白定量、组织/蛋白染色。
免疫学:抗体、免疫组化、ELISA、免疫印迹WB。
车叶草Asperula Asperuloside 车叶草苷 CAS号: 14259-45-1 分子式: C18H22O11 含量: ≥98%
车桑子Dodo
naea viscosa Aliarin 5,7-二羟基-2-[4-羟基-3-(4-羟基-3-甲基丁基)苯基]-3,6-二甲氧基-4H-1-苯并吡喃-4-酮 CAS号: 84294-77-9 分子式: C22H24O8 含量: ≥95%
车桑子Dodo
naea viscosa 3,5-Diprenyl-4-hydroxybenzaldehyde 4-羟基-3,5-双(3-甲基-2-丁烯-1-基)苯甲醛 CAS号: 52275-04-4 分子式: C17H22O2 含量: ≥95%
车桑子Dodo
naea viscosa 3,6-Dimethoxyapigenin 5,7,4'-三羟基-3,6-二甲氧基黄酮 CAS号: 22697-65-0 分子式: C17H14O7 含量: ≥95%
车桑子Dodo
naea viscosa Dodo
nolide (6R,7S,8E,10Z)-7-[2-(3-呋喃基)乙基]-4,5,6,7-四氢-6,7-二甲基环癸并[c]呋喃-1(3H)-酮 CAS号: 349534-73-2 分子式: C20H24O3 含量: ≥95%
车桑子Dodo
naea viscosa Dodoviscin A none CAS号: 1372527-25-7 分子式: C27H32O9 含量: ≥95%
车桑子Dodo
naea viscosa Dodoviscin H (-)-5,7-二羟基-2-[4-羟基-3-(4-羟基-3-甲基丁基)-5-(3-甲基-2-丁烯-1-基)苯基]-3-甲氧基-4H-1-苯并吡喃-4-酮 CAS号: 1372527-39-3 分子式: C26H30O7 含量: ≥95%
车桑子Dodo
naea viscosa Dodoviscin I (+)-5,7-二羟基-2-[4-羟基-3-(4-羟基-3-甲基丁基)苯基]-3-甲氧基-4H-1-苯并吡喃-4-酮 CAS号: 1372527-40-6 分子式: C21H22O7 含量: ≥95%
rcells. This PTP has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. This PTP also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. Four alternatively spliced transcripts variants of this gene, which encode distinct isoforms, have been reported. [provided by RefSeq, Jul 2008].
Function : Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN. Dephosphorylates LYN, and thereby modulates LYN activity.
Subunit : Binds GANAB and PRKCSH. Interacts with SKAP1. Interacts with DPP4; the interaction is enhanced in a interleukin-12-dependent manner in activated lymphocytes. Contains 2 tyrosine-protein phosphatase domains.
Subcellular Location : Membrane; Single-pass type I membrane protein. Membrane raft. Note=Colocalized with DPP4 in membrane rafts.
Post-translational modifications : Heavily N- and O-glycosylated.
3,4,5-三甲氧基肉桂酸 90-50-6价格DISEASE : Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent,